USAAdd to My Companies | Give a Referral for this Company | Print this Profile
Company details, activities, locations, contacts, financials and reviews for Caribou Biosciences, Inc.
Main company details for Caribou Biosciences, Inc.
Caribou is a leading clinical-stage biotechnology company, founded by pioneers of CRISPR biology, using CRISPR genome editing to discover and develop immune cell-based therapeutics for cancer. Caribou believes that cell therapies are critical now and for the future of cancer therapy and that genome editing is necessary to develop sophisticated cell therapies to treat a variety of different malignancies. The Company is developing a pipeline of genome-edited off-the-shelf CAR-T cell and natural killer (NK) cell therapies for a range of tumor types. Additionally, Caribou offers licenses to its CRISPR-Cas9 foundational IP in multiple fields including research tools, internal research use, diagnostics, and industrial biotechnology.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for Caribou Biosciences, Inc on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.